Related Experiment Video
Updated: Jan 24, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
A novel long non-coding RNA TONSL-AS1 regulates progression of gastric cancer via activating TONSL
Peng Wang1, Xi Yang2, Liang Zhao3
1Department of General Surgery, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University. No.1399, Shichang Road, Shengze Town, Suzhou City, Jiangsu, China; Department of General Surgery, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine. No.1-1, Zhongfu Road, Nanjing, Jiangsu, China.
Abstract:
Long non-coding RNAs (lncRNAs) are reported to play a significant role in various malignant tumors, yet their potential functions in gastric cancer are not clear. In this study, we found a novel lncRNA, named TONSL-AS1, was downregulated in gastric cancer tissues and cell lines compared with the normal. TONSL-AS1 inhibited cell migration, invasion and proliferation in SGC-7901, MGC-803 cells. Furthermore, TONSL-AS1 could suppress cell tumorigenesis in vivo. Mechanistically, TONSL-AS1's genomic neighboring gene TONSL, which was reported as a tumor suppress gene, was upregulated by TONSL. Additionally, the TONSL-AS1 was positively associated with TONSL in cancer tissues. Our study revealed that the tumor-inhibiting effect of TONSL-AS1 in gastric cancer cells was associated with TONSL. In general, our results indicated that TONSL-AS1 works as a tumor suppressor lncRNA, which may be a new therapeutic target for gastric cancer.
Insights
A novel long non-coding RNA (lncRNA), TONSL-AS1, acts as a tumor suppressor in gastric cancer. It inhibits cell growth and metastasis, offering a potential new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are implicated in various cancers.
- The specific roles of lncRNAs in gastric cancer remain largely undefined.
- Identifying novel regulatory mechanisms is crucial for gastric cancer treatment.
Purpose of the Study:
- To investigate the function of a novel lncRNA, TONSL-AS1, in gastric cancer.
- To elucidate the molecular mechanism underlying TONSL-AS1's role in gastric cancer.
- To assess TONSL-AS1 as a potential therapeutic target for gastric cancer.
Main Methods:
- Quantitative real-time PCR to assess TONSL-AS1 expression in gastric cancer tissues and cell lines.
- In vitro assays (migration, invasion, proliferation) to evaluate TONSL-AS1 function.
- In vivo tumorigenesis assays to confirm tumor-suppressive effects.
- Analysis of the relationship between TONSL-AS1 and its neighboring gene TONSL.
Main Results:
- TONSL-AS1 was significantly downregulated in gastric cancer tissues and cell lines.
- Overexpression of TONSL-AS1 suppressed gastric cancer cell migration, invasion, and proliferation.
- TONSL-AS1 inhibited tumor formation in vivo.
- TONSL-AS1 positively regulated the expression of the tumor suppressor gene TONSL.
Conclusions:
- TONSL-AS1 functions as a tumor suppressor in gastric cancer.
- The tumor-inhibiting effect of TONSL-AS1 is mediated through the regulation of TONSL.
- TONSL-AS1 represents a promising novel therapeutic target for gastric cancer.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Neural Regulation
Regulated mRNA Transport
Hormonal Regulation

